These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36618132)

  • 21. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
    Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
    JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update.
    Chopra A; Sivaraman K; Radhakrishnan R; Balakrishnan D; Narayana A
    Jpn Dent Sci Rev; 2021 Nov; 57():39-45. PubMed ID: 33747261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19.
    Matsuyama A; Okura H; Hashimoto S; Tanaka T
    Sci Rep; 2022 Nov; 12(1):20449. PubMed ID: 36443363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study.
    Fantozzi PJ; Pampena E; Pierangeli A; Oliveto G; Sorrentino L; Di Vanna D; Pampena R; Lazzaro A; Gentilini E; Mastroianni CM; D'Ettorre G; Polimeni A; Romeo U; Villa A
    Am J Otolaryngol; 2022; 43(6):103549. PubMed ID: 35988522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients.
    Sulistyani LD; Julia V; Soeprapto A; Swari RP; Rosmanato F; Haryanto B; Cahyarini C; Panjaitan R; Maharani DA
    F1000Res; 2022; 11():1238. PubMed ID: 38988895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.
    De Boeck I; Cauwenberghs E; Spacova I; Gehrmann T; Eilers T; Delanghe L; Wittouck S; Bron PA; Henkens T; Gamgami I; Simons A; Claes I; Mariën J; Ariën KK; Bakokimi D; Loens K; Jacobs K; Ieven M; Bruijning-Verhagen P; Delputte P; Coenen S; Verhoeven V; Lebeer S
    Microbiol Spectr; 2022 Oct; 10(5):e0168222. PubMed ID: 36154666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.
    Pantazopoulos I; Chalkias A; Mavrovounis G; Dimeas I; Sinis S; Miziou A; Rouka E; Poulas K; Gourgoulianis K
    Can Respir J; 2022; 2022():8794127. PubMed ID: 36247079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virucidal effect of povidone-iodine against SARS-CoV-2
    Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
    J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Povidone-Iodine Solution: A Potential Antiseptic to Minimize the Risk of COVID-19? A Narrative Review.
    Castro-Ruiz C; Vergara-Buenaventura A
    J Int Soc Prev Community Dent; 2020; 10(6):681-685. PubMed ID: 33437699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.